Assessment according to §137h SGB V

Implantation via injection under endoscopic ultrasound guidance of 32P-labeled microparticles for unresectable, locally advanced pancreatic tumours

Status
Status: Commission completed
Project no.
H21-13
Last updated

Report documents

  1. Extract of the assessment according to §137h SGB V

    Implantation via injection under endoscopic ultrasound guidance of 32P-labeled microparticles for unresectable, locally advanced pancreatic tumours

    published on
    Document type
    PDF document, 175 kB, EN, not accessible
  2. Assessment according to §137h SGB V

    Implantation via injection under endoscopic ultrasound guidance of 32P-labeled microparticles for unresectable, locally advanced pancreatic tumours

    published on
    Document type
    PDF document, 520 kB, DE, not accessible

Press releases

High-risk medical devices: No comparative data available for two new methods

IQWiG assessed one new invasive procedure each for the treatment of pancreatic tumours and uterine fibroids. Due to a lack of robust data, the Institute outlined testing studies for both methods.

Project details

Project no.
H21-13
Commission
Commission awarded on 13.12.2021 by the Federal Joint Committee (GBA).
Report type
Assessment according to §137h SGB V
Status
Commission completed
Department/Division
Non-Drug Interventions
Topic
Cancer
Note

As part of the procedures according to §137h SGB V (German version), the Federal Joint Committee (GBA) commissioned IQWiG to assess this examination or treatment method.

Connected Projects

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form